Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.27 - $8.26 $207,287 - $400,981
-48,545 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.07 - $11.62 $154,840 - $254,489
-21,901 Reduced 31.09%
48,545 $389,000
Q4 2021

Feb 14, 2022

SELL
$10.49 - $14.28 $3,776 - $5,140
-360 Reduced 0.51%
70,446 $820,000
Q3 2021

Nov 15, 2021

BUY
$9.94 - $12.77 $703,811 - $904,192
70,806 New
70,806 $877,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.